Publications

29. Patente et al., PLoS Pathogens (2024) S. mansoni -derived omega-1 prevents OVA-specific allergic airway inflammation via hampering of cDC2 migration

28. Jorssen et al., Immunity (2024) Single-cell proteomics and transcriptomics capture eosinophil development and identify the role of IL-5 in their lineage transit amplification

27. De Haas, Stolk, Schetters et al., Pharmaceutics (2024) Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells

26. Schetters*, Dammeijer, Desmet, Frontiers in Immunology (2023) The development and plasticity of myeloid immunity in the lung

25. van Damma et al., Science Translational Medicine (2023) A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19

24. van Gulijk, van Krimpen, Schetters et al., Science Immunology (2023) PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance

23. Rodriguez et al., Communications Biology (2022) Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits

22. Lambrecht, Aegerter, Schetters, Eosinophilic Lung Diseases (ERS Monograph) (2022) Future prospects of translational and clinical eosinophil research

21. Schetters* & Schuijs, Frontiers in Immunology (2021) Pulmonary Eosinophils at the Center of the Allergic Space-Time Continuum

20. De Goede et al., Cancers (2021) Myeloid-Specific Acly Deletion Alters Macrophage Phenotype In Vitro and In Vivo without Affecting Tumor Growth

19. Stolk, Horrevorts & Schetters et al., Molecular Therapy – Oncolytics (2021) Palmitoylated antigens for the induction of anti-tumor CD8⁺ T-cells and enhanced tumor recognition

18. Rodriguez et al., Nature Communications (2021) Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9

17. Hofland et al., European Journal of Immunology (2020) Human CXCR5+PD‐1+ CD8 T cells in healthy individuals and patients with hematologic malignancies

16. Dammeijer & van Gulijk et al., Cancer Cell (2020) The PD-1PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes

15. Schetters* et al., Biomaterials (2020) Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity

14. Schetters et al., The FASEB Journal (2020) Immunological dynamics after subcutaneous immunization with a squalene‐based oil‐in‐water adjuvant

13. Schetters* et al., Journal for Immunotherapy of Cancer (2020) Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy

12. Crommentuijn & Schetters et al., Journal for Immunotherapy of Cancer (2020) Immune involvement of the contralateral hemisphere in a glioblastoma mouse model

11. Duinkerken et al., Current opinion in chemical biology (2019) Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells

10. Schetters et al., Cellular and Molecular Immunology (2019) Bacterial inclusion bodies function as vehicles for dendritic cell-mediated T cell responses

9. Schetters et al., Acta Biomaterialia (2019) Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8⁺ T cells

8. Schetters et al., Frontiers in Immunology (2018) Mouse DC-SIGN/CD209a as target for antigen delivery and adaptive immunity

7. Rodriguez, Schetters, Van Kooyk, Nature Reviews Immunology (2018) The tumour glyco-code as a novel immune checkpoint for immunotherapy

6. Van Dinther et al., Cell Reports (2018) Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8⁺ T Cell Cross-Priming

5. Schetters et al., Frontiers in Immunology (2018) Neuroinflammation: Microglia and T Cells Get Ready to Tango

4. Kamphuis et al., BBA – Molecular Basis of Disease (2016) Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer’s disease

3. Perdicchio et al., Proceedings of the National Academy of Sciences (2016) Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells

2. Olmos-Alonso & Schetters et al., Brain (2016) Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology

1. Gomez-Nicola, Schetters & Perry, GLIA (2014) Differential role of CCR2 in the dynamics of microglia and perivascular macrophages during prion disease

* Corresponding author